<?xml version="1.0"?>
<notificationOfRemoval>

    <schemaVersion>X0203</schemaVersion>

    <exchange>
        <cik>0001354457</cik>
        <entityName>Nasdaq Stock Market LLC</entityName>
    </exchange>

    <issuer>
        <cik>0001348362</cik>
        <entityName>Lexaria Bioscience Corp.</entityName>
        <fileNumber>001-39874</fileNumber>
        <address>
            <street1>100 - 740 McCurdy Road</street1>
            <street2></street2>
            <city>Kelowna/ British Columbia</city>
            <stateOrCountryCode>IL</stateOrCountryCode>
            <stateOrCountry>ILLINOIS</stateOrCountry>
            <zipCode>V1X 2P7</zipCode>
        </address>
        <telephoneNumber>250-765-6424 (203)</telephoneNumber>
    </issuer>

    <descriptionClassSecurity>warrant</descriptionClassSecurity>

    <ruleProvision>17 CFR 240.12d2-2(a)(2)</ruleProvision>

    <signatureData>
        <signatureName>Tara Petta</signatureName>
        <signatureTitle>AVP</signatureTitle>
        <signatureDate>2026-01-13</signatureDate>
    </signatureData>
</notificationOfRemoval>
